Bibliography
- Schousboe A . Pharmacological and functional characterization of astrocytic GABA transport: a short review.Neurochem. Res.25, 1241–1244 (2000).
- Madsen KK , WhiteHS, SchousboeA. Neuronal and non-neuronal GABA transporters as targets for antiepileptic drugs.Pharmacol. Ther.125, 394–401 (2010).
- Schousboe A , SarupA, BakLK, WaagepetersenHS, LarssonOM. Role of astrocytic transport processes in glutamatergic and GABAergic neurotransmission.Neurochem. Int.45, 512–527 (2004).
- Clausen RP , MadsenK, LarssonOM, Fr⊘lundB, Krogsgaard-LarsenP, SchousboeA. Structure–activity relationship and pharmacology of γ-aminobutyric acid (GABA) transport inhibitors.Adv. Pharmacol.54, 265–284 (2006).
- Madsen K , WhiteHS, ClausenRPet al. Functional and pharmacological aspects of GABA-transporters. In: Handbook of Neurochemistry and Molecular Neurobiology (3rd Edition): Neural Membranes and Transport. Lajtha A, Reith M (Eds). Springer Verlag Berlin, Heidelberg, Germany 285–304 (2007).
- Falch E , PerregaardJ, Fr⊘lundBet al. Selective inhibitors of glial GABA uptake: synthesis, absolute stereochemistry and pharmacology of the enantiomers of 3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole (exo-THPO) and analogues. J. Med. Chem. 42, 5402–5414 (1999).
- White HS , SarupA, BolvigTet al. Correlation between anticonvulsant activity and inhibitory action on glial GABA uptake of the highly selective mouse GAT1 inhibitor 3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole (exo-THPO) and its N-alkylated analogs. J. Pharmacol. Exp. Therap. 302, 636–644 (2002).
- Clausen RP , MoltzenEK, PerregaardJet al. Selective inhibitors of GABA uptake: synthesis and molecular pharmacology of 3-hydroxy-4-N-methylamino-4,5,6,7-tetrahydro-1,2-benzo[d]isoxazole analogues. Bioorg. Med. Chem. 13, 895–908 (2005).
- White HS , WatsonWP, HansenSet al. First demonstration of a functional role for CNS betaine/GABA transporter (mGAT2) based on synergistic anticonvulsant action among inhibitors of mGAT1 and mGAT2. J. Pharmacol. Exp. Therap. 312, 866–874 (2005).
- Clausen RP , Fr⊘lundB, LarssonOM, SchousboeA, Krogsgaard-LarsenP, WhiteHS. A novel selective γ-aminobutyric acid transport inhibitor demonstrates a functional role for GABA transporter subtype GAT2/BGT-1 in the CNS.Neurochem. Int.48, 637–642 (2006).
- Thomsen C , S⊘rensenPO, EgebjergJ. 1-(3-(9H-carbazol-9-yl)-1-propyl)-4-(2-methoxyphenyl)-4-piperidinol, a novel subtype selective inhibitor of the mouse type II GABA- transporter.Br. J. Pharmacol.120, 983–985 (1997).
- Schousboe A , WhiteHS. Modulation of excitability via glutamate and GABA transporters. In: Encyclopedia of Basic Epilepsy Research (Vol. 1). Schwartzkroin P (Ed.). Elsevier Ltd, Oxford, UK, 397–401 (2009).
- H⊘g S , GreenwoodJR, MadsenKBet al. Structure–activity relationships of selective GABA uptake inhibitors. Curr. Top. Med. Chem. 6, 1861–1882 (2006).
- Yamashita A , SinghSK, KawateT, JinY, GouauxE. Crystal structure of a bacterial homologue of Na+/Cl–-dependent neurotransmitter transporters. Nature437, 215–223 (2005).
- Kardos J , PalloA, BencsuraA, SimonA. Assessing structure, function and druggability of major inhibitory neurotransmitter γ-aminobutyrate symporter subtypes.Curr. Med. Chem.17, 2203–2213 (2010).
- Madsen KB , ClausenRP, LarssonOM, Krogsgaard-LarsenP, SchousboeA, WhiteHS. Synaptic and extrasynaptic GABA transporters as targets for anti-epileptic drugs.J. Neurochem.109(Suppl. 1), 139–144 (2009).
- Krogsgaard-Larsen P , Fr⊘lundB, LiljeforsT. GABAA agonists and partial agonists: THIP (Gaboxadol) as a non-opioid analgesic and a novel type of hypnotic. Adv. Pharmacol.54, 53–71 (2006).
- Thomsen C , EbertB. Modulators of the GABAA receptor. In: Glutamate and GABA Receptors and Transporters. Egebjerg J, Schousboe A, Krogsgaard-Larsen P (Eds). Taylor and Francis, London, UK, 407–427 (2002).
- Madsen KK , EbertB, ClausenRPet al. The selective GAT inhibitors tiagabine and N-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-hydroxy-4-(methylamino)-4,5,6,7-tetrahydrobenzo[d]isoxazol-3-ol (EF 1502) exhibit mechanistic differences in their ability to modulate the ataxia and anticonvulsant action of the extrasynaptic GABA-A receptor agonist gaboxadol. J. Pharmacol. Exp. Therap. (2011) (In Press).